Condition: Chronic Widespread Pain · Sponsor: Florida International University
To determine if decreased production or release of endogenous opioid peptides by peripheral immune cells contributes to hypersensitivity in people with HIV
This description comes directly from the study's public registry record.
Saurabh Aggarwal, MD., PhD · 305-348-9634 · saaggarw@fiu.edu
Always discuss trial participation with your own doctor first.
| Ambulatory Care Center, Florida International University | Miami, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04787848